Nicole Blazek, Senior Clinical Content Editor

Most Recent Articles by Nicole Blazek, Senior Clinical Content Editor

NIH Requests Additional Funds to Treat Alzheimer's Disease

By

Targeted milestones, areas poised for future discoveries, and areas of research that could benefit the most prioritized.

AVP-923 Reduces Agitation in Patients with Alzheimer's Disease

AVP-923 Reduces Agitation in Patients with Alzheimer's Disease

By

Currently FDA-approved for treating pseudo bulbar affect, the drug also benefits agitation.

Can Amyloid PET Scans Improve Dementia Outcomes?

Can Amyloid PET Scans Improve Dementia Outcomes?

By

The first randomized-controlled clinical trials are underway to assess if early access to amyloid imaging PET scan results can inform treatment decisions for mild cognitive impairment and dementia.

Solanezumab Shows Modest Effect on Alzheimer's Disease Progression

Solanezumab Shows Modest Effect on Alzheimer's Disease Progression

By By

Investigators identified a possible disease-modifying effect of solanezumab as an early treatment for Alzheimer's disease, but the benefit in clinical practice remains unclear.

Memory Decline More Rapid in Women Than Men

Memory Decline More Rapid in Women Than Men

By

Among those with mild cognitive impairment, women's cognitive abilities deteriorated twice as quickly as men.

More Articles by Nicole Blazek, Senior Clinical Content Editor

Sign Up for Free e-newsletters